+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Animal Health Active Pharmaceutical Ingredients Market Research Report by Business (Captive API and Merchant API), Indication, Synthesis, Type, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 122 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5367989
UP TO OFF until Dec 31st 2022
The United States Animal Health Active Pharmaceutical Ingredients Market size was estimated at USD 3,036.49 million in 2021, USD 3,446.39 million in 2022, and is projected to grow at a CAGR 9.95% to reach USD 5,366.54 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Animal Health Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Business, the market was studied across Captive API and Merchant API.
  • Based on Indication, the market was studied across Anti-infectives, Antiparasitics, and NSAIDs & Anesthetics.
  • Based on Synthesis, the market was studied across Biotech and Synthetic.
  • Based on Type, the market was studied across Branded and Generic.
  • Based on End User, the market was studied across Pet Care Hospitals and Retail and specialty pharmacies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Animal Health Active Pharmaceutical Ingredients market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Health Active Pharmaceutical Ingredients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Animal Health Active Pharmaceutical Ingredients Market, including Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Ltd., Glenmark Pharmaceutical Ltd., Huvepharma, Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ningxia Tairui Pharma CO. Ltd., Ofichem BV, Omkar Speciality Chemicals Limited, ouro fino saude animal, P&R SpA (Olon SpA), Sanofi Winthrop Industrie (CEPiA), Sequent Scientific Ltd., Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shanghai Pharmtech Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Animal Health Active Pharmaceutical Ingredients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Animal Health Active Pharmaceutical Ingredients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Animal Health Active Pharmaceutical Ingredients Market?
4. What is the competitive strategic window for opportunities in the United States Animal Health Active Pharmaceutical Ingredients Market?
5. What are the technology trends and regulatory frameworks in the United States Animal Health Active Pharmaceutical Ingredients Market?
6. What is the market share of the leading vendors in the United States Animal Health Active Pharmaceutical Ingredients Market?
7. What modes and strategic moves are considered suitable for entering the United States Animal Health Active Pharmaceutical Ingredients Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Animal Health Active Pharmaceutical Ingredients Market, by Business
6.1. Introduction
6.2. Captive API
6.3. Merchant API
7. Animal Health Active Pharmaceutical Ingredients Market, by Indication
7.1. Introduction
7.2. Anti-infectives
7.3. Antiparasitics
7.4. NSAIDs & Anesthetics
8. Animal Health Active Pharmaceutical Ingredients Market, by Synthesis
8.1. Introduction
8.2. Biotech
8.3. Synthetic
9. Animal Health Active Pharmaceutical Ingredients Market, by Type
9.1. Introduction
9.2. Branded
9.3. Generic
10. Animal Health Active Pharmaceutical Ingredients Market, by End User
10.1. Introduction
10.2. Pet Care Hospitals
10.3. Retail and specialty pharmacies
11. California Animal Health Active Pharmaceutical Ingredients Market12. Florida Animal Health Active Pharmaceutical Ingredients Market13. Illinois Animal Health Active Pharmaceutical Ingredients Market14. New York Animal Health Active Pharmaceutical Ingredients Market15. Ohio Animal Health Active Pharmaceutical Ingredients Market16. Pennsylvania Animal Health Active Pharmaceutical Ingredients Market17. Texas Animal Health Active Pharmaceutical Ingredients Market
18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis
18.3. Market Share Analysis, By Key Player
18.4. Competitive Scenario
18.4.1. Merger & Acquisition
18.4.2. Agreement, Collaboration, & Partnership
18.4.3. New Product Launch & Enhancement
18.4.4. Investment & Funding
18.4.5. Award, Recognition, & Expansion
19. Company Usability Profiles
19.1. Blanver Farmoquimica E Farmaceutica S.A.
19.2. Changzhou Yabang-Qh Pharmachem Co., Ltd.
19.3. Eli Lilly & Co.
19.4. Excel Industries Ltd.
19.5. Glenmark Pharmaceutical Ltd.
19.6. Huvepharma
19.7. Indukern, S.A.
19.8. Lonza Group AG
19.9. NGL Fine Chem Ltd.
19.10. Ningxia Tairui Pharma CO. Ltd.
19.11. Ofichem BV
19.12. Omkar Speciality Chemicals Limited
19.13. ouro fino saude animal
19.14. P&R SpA (Olon SpA)
19.15. Sanofi Winthrop Industrie (CEPiA)
19.16. Sequent Scientific Ltd.
19.17. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
19.18. Shanghai Pharmtech Co. Ltd.
19.19. Zhejiang Hisun Pharmaceutical Co. Ltd
19.20. Zoetis Inc.
20. Appendix
20.1. Discussion Guide
20.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
FIGURE 8. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2027
FIGURE 11. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2027
FIGURE 18. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2021 VS 2027 (%)
FIGURE 25. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2021 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2027
FIGURE 27. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 32. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2027
FIGURE 34. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 39. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2027
FIGURE 41. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 45. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 53. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 22. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 23. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 24. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 25. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 26. CALIFORNIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 27. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 29. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 30. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 31. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 32. FLORIDA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 33. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 35. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 36. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 37. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 38. ILLINOIS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 39. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 41. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 42. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 43. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 44. NEW YORK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 45. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 47. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 48. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 49. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 50. OHIO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 51. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 53. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 54. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 55. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 57. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2019-2027 (USD MILLION)
TABLE 59. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 60. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2019-2027 (USD MILLION)
TABLE 61. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 62. TEXAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 64. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 65. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 66. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RANKING
TABLE 67. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 68. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET MERGER & ACQUISITION
TABLE 69. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 70. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 71. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET INVESTMENT & FUNDING
TABLE 72. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 73. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: LICENSE & PRICING

Companies Mentioned

  • Blanver Farmoquimica E Farmaceutica S.A.
  • Changzhou Yabang-Qh Pharmachem Co., Ltd.
  • Eli Lilly & Co.
  • Excel Industries Ltd.
  • Glenmark Pharmaceutical Ltd.
  • Huvepharma
  • Indukern, S.A.
  • Lonza Group AG
  • NGL Fine Chem Ltd.
  • Ningxia Tairui Pharma CO. Ltd.
  • Ofichem BV
  • Omkar Speciality Chemicals Limited
  • ouro fino saude animal
  • P&R SpA (Olon SpA)
  • Sanofi Winthrop Industrie (CEPiA)
  • Sequent Scientific Ltd.
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Shanghai Pharmtech Co. Ltd.
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Zoetis Inc.

Methodology

Loading
LOADING...